What indicators would you like to setup a trade for?

Candlestick Daily volume index Bar reversal Edit

Trade setup

Position Order Entry Exit Stop Loss Risk Return Expectancy
Long 10 4.5 20% 25% 1.6% -0.8% -3.4%
Short 5 4.2 40% 67% 1.9% -3.2% -5.9%

What indicators would you like to backtest?

Candlestick Daily volume index Bar reversal Edit

Backtest results

Position Trades Duration Win rate Win/loss Avg win Avg loss Return
Long 10 4.5 20% 25% 1.6% -0.8% -3.4%
Short 5 4.2 40% 67% 1.9% -3.2% -5.9%



Code Company Date Close Change Indicator Value Signal

Trading Performance

On Balance Volume



Position Trades Duration Win Rate Win/Loss Avg Win Avg Loss Return
LONG 28 12.8 0.36% 0.50% 36.8% -4.7% 273.5%
SHORT 27 15.7 0.41% 0.61% 3.7% -6.0% -67.7%


Technical Analysis

Opthea (OPT.AX)



Last Signal:


Trading: SELL @ $3
Signal Strength: MEDIUM

Opthea (ASX:OPT) current price has highlighted recent distribution. Currently, the OBV is -57625.9.

Indicator can be used in isolation or in additional to another technical indicator to confirmation for trading exit. Indicator can be applied to the short/medium term timeframe, but the best results are obtained with larger cyclical swings in-line with the trend direction. This accumulation / distribution oscillator can provide guidance on the money flow direction from the companies recent trading.

On Balance Volume (OBV) attempts to measure the level of accumulation or distribution by comparing volume to price movements. Volume is added to the indicator if closing price moves up and subtracted if closing price moves down. No adjustment is made if closing price is unchanged.

Calculation: On Balance Volume:
1) If the closing price is above the prior close price then: Current OBV = Previous OBV + Current Volume;
2) If the closing price is below the prior close price then: Current OBV = Previous OBV - Current Volume;
3) If the closing prices equals the prior close price then: Current OBV = Previous OBV (no change)


Stock Exchange: ASX
Company: Opthea
Ticker Codes: | OPT.AX | ASX:OPT |

About Opthea (ASX:OPT):

Opthea Limited develops and commercializes therapies primarily for eye disease in Australia. The company's development activities are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors (VEGF) C and D, and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. Its lead molecule is OPT-302, a soluble form of VEGFR-3, which is in Phase 1/2A clinical trial for the treatment of back of the eye diseases, such as wet age-related macular degeneration that is the cause of blindness in elderly and diabetic populations. The company was formerly known as Circadian Technologies Limited and changed its name to Opthea Limited in December 2015. Opthea Limited is based in South Yarra, Australia.

Top 10:

On Balance Volume

Company Close Change(%) Volume Value Signal
IFM Infomedia 2.15 16.8 1,445,495 -93.6 BEARISH
AJX Alexium International 0.06 14 224,969 -119,586.5 BEARISH
UOS United Overseas Australia 0.8 9.6 110,847 -52,450.1 BEARISH
MWY Midway 1.57 9.4 91,626 -86,157.4 BEARISH
DNK Danakali 0.57 8.7 180,001 -13,372.1 BEARISH
BEE Broo 0.01 8.3 583,427 -59,013.2 BEARISH
MNS Milnes Holdings 0.08 7.1 959,142 -463,223 BEARISH
GSW Getswift 0.57 6.5 140,748 -43,742.5 BEARISH
ALK Alkane Exploration 0.91 6.5 4,762,492 -1,078,838.4 BEARISH
APE Ap Eagers Holdings 9.01 6.1 633,117 -17,183.8 BEARISH